1mmk: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="1mmk" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mmk, resolution 2.0Å" /> '''Crystal structure of...
 
No edit summary
Line 1: Line 1:
[[Image:1mmk.gif|left|200px]]<br />
[[Image:1mmk.gif|left|200px]]<br /><applet load="1mmk" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1mmk" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1mmk, resolution 2.0&Aring;" />
caption="1mmk, resolution 2.0&Aring;" />
'''Crystal structure of ternary complex of the catalytic domain of human phenylalanine hydroxylase ((FeII)) complexed with tetrahydrobiopterin and thienylalanine'''<br />
'''Crystal structure of ternary complex of the catalytic domain of human phenylalanine hydroxylase ((FeII)) complexed with tetrahydrobiopterin and thienylalanine'''<br />


==Overview==
==Overview==
The crystal structures of the catalytic domain of human phenylalanine, hydroxylase (hPheOH) in complex with the physiological cofactor, 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH(4)) and the substrate, analogues 3-(2-thienyl)-L-alanine (THA) or L-norleucine (NLE) have been, determined at 2.0A resolution. The ternary THA complex confirms a previous, 2.5A structure, and the ternary NLE complex shows that similar large, conformational changes occur on binding of NLE as those observed for THA., Both structures demonstrate that substrate binding triggers structural, changes throughout the entire protomer, including the displacement of, Tyr138 from a surface position to a buried position at the active site, with a maximum displacement of 20.7A for its hydroxyl group. Two, hinge-bending regions, centred at Leu197 and Asn223, act in consort upon, substrate binding to create further large structural changes for parts of, the C terminus. Thus, THA/L-Phe binding to the active site is likely to, represent the epicentre of the global conformational changes observed in, the full-length tetrameric enzyme. The carboxyl and amino groups of THA, and NLE are positioned identically in the two structures, supporting the, conclusion that these groups are of key importance in substrate binding, thus explaining the broad non-physiological substrate specificity observed, for artificially activated forms of the enzyme. However, the specific, activity with NLE as the substrate was only about 5% of that with THA, which is explained by the different affinities of binding and different, catalytic turnover.
The crystal structures of the catalytic domain of human phenylalanine hydroxylase (hPheOH) in complex with the physiological cofactor 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH(4)) and the substrate analogues 3-(2-thienyl)-L-alanine (THA) or L-norleucine (NLE) have been determined at 2.0A resolution. The ternary THA complex confirms a previous 2.5A structure, and the ternary NLE complex shows that similar large conformational changes occur on binding of NLE as those observed for THA. Both structures demonstrate that substrate binding triggers structural changes throughout the entire protomer, including the displacement of Tyr138 from a surface position to a buried position at the active site, with a maximum displacement of 20.7A for its hydroxyl group. Two hinge-bending regions, centred at Leu197 and Asn223, act in consort upon substrate binding to create further large structural changes for parts of the C terminus. Thus, THA/L-Phe binding to the active site is likely to represent the epicentre of the global conformational changes observed in the full-length tetrameric enzyme. The carboxyl and amino groups of THA and NLE are positioned identically in the two structures, supporting the conclusion that these groups are of key importance in substrate binding, thus explaining the broad non-physiological substrate specificity observed for artificially activated forms of the enzyme. However, the specific activity with NLE as the substrate was only about 5% of that with THA, which is explained by the different affinities of binding and different catalytic turnover.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1MMK is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with FE2, SO4, H4B and TIH as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phenylalanine_4-monooxygenase Phenylalanine 4-monooxygenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.16.1 1.14.16.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1MMK OCA].  
1MMK is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=FE2:'>FE2</scene>, <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=H4B:'>H4B</scene> and <scene name='pdbligand=TIH:'>TIH</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phenylalanine_4-monooxygenase Phenylalanine 4-monooxygenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.16.1 1.14.16.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MMK OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Phenylalanine 4-monooxygenase]]
[[Category: Phenylalanine 4-monooxygenase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Andersen, O.A.]]
[[Category: Andersen, O A.]]
[[Category: Flatmark, T.]]
[[Category: Flatmark, T.]]
[[Category: Hough, E.]]
[[Category: Hough, E.]]
Line 30: Line 29:
[[Category: ferrous iron]]
[[Category: ferrous iron]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:13:05 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:56:53 2008''

Revision as of 14:56, 21 February 2008

File:1mmk.gif


1mmk, resolution 2.0Å

Drag the structure with the mouse to rotate

Crystal structure of ternary complex of the catalytic domain of human phenylalanine hydroxylase ((FeII)) complexed with tetrahydrobiopterin and thienylalanine

OverviewOverview

The crystal structures of the catalytic domain of human phenylalanine hydroxylase (hPheOH) in complex with the physiological cofactor 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH(4)) and the substrate analogues 3-(2-thienyl)-L-alanine (THA) or L-norleucine (NLE) have been determined at 2.0A resolution. The ternary THA complex confirms a previous 2.5A structure, and the ternary NLE complex shows that similar large conformational changes occur on binding of NLE as those observed for THA. Both structures demonstrate that substrate binding triggers structural changes throughout the entire protomer, including the displacement of Tyr138 from a surface position to a buried position at the active site, with a maximum displacement of 20.7A for its hydroxyl group. Two hinge-bending regions, centred at Leu197 and Asn223, act in consort upon substrate binding to create further large structural changes for parts of the C terminus. Thus, THA/L-Phe binding to the active site is likely to represent the epicentre of the global conformational changes observed in the full-length tetrameric enzyme. The carboxyl and amino groups of THA and NLE are positioned identically in the two structures, supporting the conclusion that these groups are of key importance in substrate binding, thus explaining the broad non-physiological substrate specificity observed for artificially activated forms of the enzyme. However, the specific activity with NLE as the substrate was only about 5% of that with THA, which is explained by the different affinities of binding and different catalytic turnover.

DiseaseDisease

Known diseases associated with this structure: Hyperphenylalaninemia, mild OMIM:[261600], Phenylketonuria OMIM:[261600]

About this StructureAbout this Structure

1MMK is a Single protein structure of sequence from Homo sapiens with , , and as ligands. Active as Phenylalanine 4-monooxygenase, with EC number 1.14.16.1 Full crystallographic information is available from OCA.

ReferenceReference

2.0A resolution crystal structures of the ternary complexes of human phenylalanine hydroxylase catalytic domain with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine or L-norleucine: substrate specificity and molecular motions related to substrate binding., Andersen OA, Stokka AJ, Flatmark T, Hough E, J Mol Biol. 2003 Oct 31;333(4):747-57. PMID:14568534

Page seeded by OCA on Thu Feb 21 13:56:53 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA